News Headlines Article

FTC won’t challenge effort to fight drug shortages
Modern Healthcare

The Federal Trade Commission will not recommend a challenge to a Generic Pharmaceuticals Association plan to assist the Food and Drug Administration as it tries to reduce drug shortages. Though the effort, known as the Accelerated Recovery Initiative, would have the GPhA collect competitively sensitive data that would raise antitrust concerns if it were shared with competitors, the proposed program’s safeguards would prevent such sharing from occurring, according to a news release from the FTC.